Dual diagnosis and psychosocial interventionsIntroduction and commentary

Nordic Journal of Psychiatry

Volumn 63, Issue 3, 2009, Pages 202-208

  Thylstrup, Birgitte ^a   Johansen, Katrine Schepelern ^b  

^a Center for Rusmiddelforskning   (Denmark)

^b KASA   (Denmark)

Author keywords

Dual diagnosis; Research; Treatment

Indexed keywords

COGNITIVE THERAPY; DENMARK; DIAGNOSIS; DUAL DIAGNOSIS; FAMILY THERAPY; HUMAN; INTERVIEW; MENTAL DISEASE; MENTAL HEALTH; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; REVIEW; SUBSTANCE ABUSE; ADDICTION; COMORBIDITY; METHODOLOGY; MOTIVATION; PREVALENCE; PSYCHIATRIC DIAGNOSIS;

COGNITIVE THERAPY; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FAMILY THERAPY; GUIDELINES AS TOPIC; HUMANS; MENTAL DISORDERS; MOTIVATION; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 70349573934     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480802571069     Document Type: Review

References (63)

1. Blanchard JJ. The co-occurrence of substance use in other mental disorders: Editor's introduction. Clin Psychol Rev 2000;/20:/145-8.
2. Armstrong TD, Costello EJ. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol 2002;/70:/1224-39.
3. O'Brien CP, Charney DS, Lewis L, Cornish JW, Post RM, Woody GE, et al. Priority actions to improve care of persons with cooccuring substance abuse and other mental disorders: A call to action. Biol Psychiatry 2004;/15:/703-13.
4. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry 2004;/56:/730-7.
5. Minkoff K. Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiat Serv 2001;/52:/597-9.
6. Drake R, Essock S, Shaner A, Carey K, Minkoff K, Kola L. Implementing dual diagnosis services for clients with severe mental disorder. Psychiat Serv 2001;/52:/469-76.
7. Drake RE, Wallach MA. Dual diagnosis: 15 years of progress. Psychiat Serv 2000;/51:/1126-9.
8. Kokkevi A, Stefanis N, Anastasopoulou E, C K. Personality disorders in drug abusers: Prevalence and their association with AXIS I disorders as predictors of treatment retention. Addict Behav 1998;23:841-53.
9. Darke S, Williamson A, Ross J, Teeson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risktaking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004;/74:/77-83.
10. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998;/24:/ 443-55.
11. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 1990;/264:/2511-8.
12. Kavanagh DJ MJ, Saunders JB, Dore G, Clark D. Substance use in patients with schizophrenia*Epidemiology and management. Drugs 2002;/59:/921-8.
13. Green AI. Schizophrenia and comorbid substance use disorder: Effects of antipsychotics. J Clin Psychiatry 2005;/66(Suppl 6):/21-6.
14. Green AI, Drake RE, Brunette MF, Noordsy DL. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry 2007;/ 164:/402-8.
15. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 1996;/66:/17-31.
16. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;/61:/807-16.
17. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;/61:/361-8.
18. Vendsborg P. Indsatsen for mennesker med dobbeltdiagnose. In: Andersen KW PD, editor. Cocktail med udfordringer. En antologi om mennesker med sindslidelse og misbrug. Copenhagen: Socialt Udviklingscenter SUS; 2005.
19. Fridell M. Institutionelle behandlingsformer vid missbruk. organisation, ideologi och resultat. Borås: Natur och Kultur; 1996.
20. Evjen RT, Kielland KB. Dobbelt OPP. Om psykiske lidelser og rusmisbruk. Oslo: Universitetsforlaget; 2003.
21. Mueser K, Noordsy D, Drake R, Fox L. Integrated treatment for dual disorders. A guide to effective practice. New York: Guilford Press; 2003.
22. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L. Implementing dual diagnosis services for clients with severe mental disorder. Psychiat Serv 2001;/52:/469-76.
23. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998;/24:/ 589-608.
24. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001;/158:/1706-13.
25. Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated treatment for dual disorders: A guide to effective practice. New York: Guilford Press; 2003.
26. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorders in persons with severe mental illness. Am J Orthopsychiatry 1996;/66:/42-51.
27. Ley A, Jeffery D, McLaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2000(4).
28. Cleary M, Hunt G, Matheson S, Siegfried N, Walter N. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008(2).
29. Graham H, Copello A, Birchwood M, Orford J, McGovern D, Mueser K. A preliminary evaluation of integrated treatment for co-existing substance use and severe mental health problems: Impact on teams and service users. J Ment Health 2006;/15:/577-91.
30. Lykke J. En kognitiv model for miljøterapi. In: Oestrich I, Holm L, editors. Kognitiv miljøterapi: Gylling: Psykologisk Forlag; 2001.
31. Carroll KM. Behavioral therapies for co-occuring substance use and mood disorders. Biol Psychiatry 2004;/56:/810-6.
32. Conrod PJ. A critical look at dual-focused cognitive-behavioral treatments for comorbid substance use and psychiatric disorders: Strengths, limitations, and future directions. J Cogn Psychother 2005;/19:/261-84.
33. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N. Cognitive-behavioral therapy and motivational intervention for schizophrenia and substance use. 18 months outcome of a randomised controlled trial. Br J Psychiatry 2003;/183:/ 418-26.
34. Oestrich I, Austin S, Lykke J. The feasibility of a cognitive behavioural intervention for low self-esteem within a dual diagnosis inpatient population. Behav Cogn Psychother 2007;/35:/403-8.
35. Sciacca K. Removing barriers: Dual diagnosis and motivational interviewing. Profess Counsel 1997;/12:/41-6.
36. Rollnick S, Miller WS. What is motivational interviewing? Behav Cogn Psychother 1995;/23:/325-35.
37. Swanson AJ, Pantalon MV, Cohen KR. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Dis 1999;/187:/630-5.
38. Martino S, Carroll KM, O'Malley SO, Rounsaville BJ. Motivational interviewing with psychiatrically ill substance abusing patients. Am J Addictions 2000;/9:/88-91.
39. Heinssen RK, Levendusky PG. Client as colleague: Therapeutic contracting with the seriously mentally ill. Am Psychol 1995;/50:/ 522-32.
40. Carey KB, Purnine DM, Maisto SA, Carey MP, Simons JF. Treating substance abuse in the context of severe and persistent mental illness: Clinicians' perspectives. J Subst Abuse Treat 2000;/ 19:/189-98.
41. Martino S, Carroll K, Kostas D, Perkins J, Rounsaville B. Dual Diagnosis Motivational Interviewing: A modification of Motivational Interviewing for substance-abusing patients with psychotic disorders. J Subst Abuse Treat 2002;/23:/297-308.
42. Clark R, Mueser K. Progress in research on dual disorders. The Br J Psychiatry 2003;/183:/377-8.
43. Clark R. Family support and substance use outcomes for people with mental illnes and substance use disorders. Schizophr Bull 2001;/27:/93-101.
44. Mueser K, Fox L. A family intervention program for dual disorders. Community Ment Health J 2002;/38:/253-69.
45. Salyers M, Mueser K. Social functioning, psychopathology and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 2001;/48:/109-23.
46. Miller WR, Meyers RJ, Hiller-Sturmhöffel S. The communityreinforcement approach. Alcohol Res Health 1999;/23:/116-21.
47. Meyers RJ, Villanueva M, Smith JE. The community reinforcement approach: History and new directions. J Cogn Psychother 2005;/19:/247-60.
48. Jessen-Petersen B. Psykotiske patienter med misbrugsproblemer (Dual-diagnosis patients). Copenhagen: Copenhagen University; 1994.
49. Ege P, editor. Midt i et vadested*Danmark før kommunalreformen. Oslo: Helse- og omsorgsdepartementet og Social- og helsedirektoratet; 2006.
50. Hansen S, Munk-Jørgensen P, Guldbæk B, Solgård T, Lauszuz K, Albrectsen N. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 2000;/102:/432-8.
51. Aakerholt A. Får de dårligste pasientene god nok behandling?; 2003.
52. Sønderby L. Work in progress; 2008.
53. Å rhus A. Dagsorden for psykiatri- og Handikapudvalgets møde, d.18 november. Århus; 2002.
54. Misbrugspsykiatri Tf. Dansk Dobbeltdiagnose Netværk. In: Lotte Sønderby; 2007.
55. Lykke J, Austin S, Mørch M. Kognitiv miljøterapi og tvang i behandling af dobbeltdiagnose. Ugeskr Læger 2008;/5:/339-43.
56. Lykke J, Hesse M, Austin S, Oestrich I. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addict Behav 2008;/33:/ 292-300.
57. Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: Issues and prospects. J Subst Abuse Treat 2008;/34:/ 36-47.
58. Oestrich IH, Austin SF, Tarrier N. Conducting research in everyday psychiatric settings: Identifying the challenges to meaningful evaluation. J Psychiatr Ment Health Nurs 2007;/14:/55-63.
59. Schoenwald SK, Hoagwood K. Effectiveness, transportability, and dissemination of interventions: What matters when? Psychiat Serv 2001;/52:/1190-7.
60. Riggs PD. Treating adolescents for substance use and comorbid psychiatric disorders. Sci Pract Perspect 2033;August:18-32.
61. Topor A. At komme sig efter alvorlige psykiske lidelser. Copenhagen: Hans Reitzels Forlag; 2003.
62. Clark R, Drake R. Expenditures of time and money by families of people with severe mental illness and substance use disorders. Community Ment Health J 1994;/30:/145-63.
63. Fountain J, Griffiths P. Synthesis of qualitative research on drug use in the European Union: Report on an EMCDDA Project. Eur Addiction Res 1999;/4:/4-20.